First Horizon Corporation’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.1M Buy
13,439
+2,437
+22% +$2.49M 0.62% 51
2026
Q1
$10.1M Buy
11,002
+1,865
+20% +$1.89M 0.42% 77
2025
Q4
$9.82M Buy
9,137
+265
+3% +$253K 0.44% 74
2025
Q3
$6.77M Buy
+8,872
New +$6.6M 0.32% 94
2021
Q2
$1.08M Sell
4,692
-117
-2% -$23.5K 0.1% 139
2021
Q1
$898K Sell
4,809
-103
-2% -$20.1K 0.09% 150
2020
Q4
$829K Sell
4,912
-103
-2% -$15.4K 0.08% 150
2020
Q3
$742K Buy
+5,015
New +$776K 0.08% 137
2013
Q2
$343K Buy
+6,994
New +$381K 0.09% 180

Other funds holding LLY

First Horizon Corporation's LLY Position: Q2 2026 in Review

First Horizon Corporation increased its Eli Lilly (LLY) stake by 22% in Q2 2026, buying an estimated $2.49M and bringing the position to 13,439 shares worth $16.1M. The position accounts for 0.62% of the portfolio, ranked #51.

First Horizon Corporation first reported a position in LLY in Q2 2013 and has held it in 9 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • First Horizon Corporation held 13,439 shares of Eli Lilly worth $16.1M as of Q2 2026.
  • First Horizon Corporation bought 2,437 Eli Lilly shares in Q2 2026, an estimated $2.49M.
  • Eli Lilly made up 0.62% of First Horizon Corporation's portfolio in Q2 2026, its #51 holding.
  • First Horizon Corporation first reported a position in Eli Lilly in Q2 2013 and has held it in 9 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.